Protection gonadique contre les effets iatrogènes des traitements anticancéreux: données expérimentales
- 1 December 1995
- journal article
- Published by Springer Nature in Andrologie
- Vol. 5 (4) , 498-503
- https://doi.org/10.1007/bf03034534
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Protective effect of medroxyprogesterone acetate plus testosterone against radiation-induced damage to the reproductive function of male rats and their offspring.Proceedings of the National Academy of Sciences, 1991
- Protection of Spermatogenesis During Cancer ChemotherapyArchives of Andrology, 1987
- Antimitotic Drugs (Cyclophosphamide and Vinblastine) in the Male Rat Deaths and Behavioral Abnormalities in the OffspringJournal of Andrology, 1986
- CHILDREN FATHERED BY MEN TREATED FOR TESTICULAR CANCERThe Lancet, 1985
- Cyclophosphamide in the male rat: Behavioral effects in the adult offspringBehavioural Brain Research, 1985
- Protection of spermatogonial survival and testicular function by WR-2721 against high and low doses of radiationInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Modification of the teratogenicity and mutagenicity of cyclophosphamide with thiol compoundsTeratology, 1981
- PROTECTION FROM CYCLOPHOSPHAMIDE-INDUCED TESTICULAR DAMAGE WITH AN ANALOGUE OF GONADOTROPIN-RELEASING HORMONEThe Lancet, 1981
- PREGNANCY AFTER CHEMOTHERAPY FOR HODGKIN'S DISEASEThe Lancet, 1979
- Effect of Drug Treatment for Lymphoma on Male Reproductive CapacityAnnals of Internal Medicine, 1973